Molecular modeling and docking studies of glutamate racemase in Vibrio vulnificus CMCP6

In Silico Biology

Volumn 8, Issue 5-6, 2008, Pages 471-483

  Vidya, Natarajan ^a   Vadivukkarasi, Bagavathkumar ^a   Manivannan, Gopalakrishnan ^a   Anbarasu, Krishnan ^a  

^a HelixInfoSystems ^*  (India)

Author keywords

Docking; Glutamate racemase; Modeller; Vibrio vulnificus

Indexed keywords

AMINO ACID ISOMERASES; AMINO ACID SEQUENCE; CATALYTIC DOMAIN; COMPUTER SIMULATION; CONSERVED SEQUENCE; ENZYME INHIBITORS; HYDROGEN BONDING; IMAGING, THREE-DIMENSIONAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; VIBRIO VULNIFICUS;

EID: 58149373923     PISSN: 13866338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. van Heijenoort, J. (2001). Formation of the glycan chains in the synthesis of bacterial peptidoglycan. Glycobiology 11, 25R-36R.
2. van Heijenoort, J. (1998). Assembly of the monomer unit of bacterial peptidoglycan. Cell. Mol. Life Sci. 54, 300-304.
3. Newsholme, P., Procopio, J., Lima, M. M., Pithon-Curi, T. C. and Curi, R. (2003). Glutamine and glutamate - their central role in cell metabolism and function. Cell. Biochem. Funct. 21, 1-9.
4. de Dios, A., Prieto, L., Mart'yn, J. A., Rubio, A., Ezquerra, J., Tebbe, M., López de Uralde, B., Martín, J., Sánchez, A., LeTourneau, D. L., McGee, J. E., Boylan, C., Parr, T. R. Jr. and Smith, M. C. (2002). 4-Substituted D-glutamic acid analogues: The first potent inhibitors of glutamate racemase (MurI) enzyme with antibacterial activity. J. Med. Chem. 45, 4559-4570.
5. Glavas, S. and Tanner, M. E. (2001). Active site residues of glutamate racemase. Biochemistry 40, 6199-6204.
6. Gulig, P. A., Bourdage, K. L. and Starks, A. M. (2005). Molecular pathogenesis of Vibrio vulnificus. J. Microbiol. 43, 118-131.
7. Oliver, J. D. (2005). Wound infections caused by Vibrio vulnificus and other marine bacteria. Epidemiol. Infect. 133, 383-391.
8. Bross, M. H., Soch, K., Morales, R. and Mitchell, R. B. (2007). Vibrio vulnificus infection: Diagnosis and treatment. Am. Fam. Physician. 76, 539-544.
9. Linkous, D. A. and Oliver, J. D. (1999). Pathogenesis of Vibrio vulnificus. FEMS Microbiol. Lett. 174, 207-214.
10. Strom, M. S. and Paranjpye, R. N. (2000). Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2, 177-188.
11. Yoshida, S., Ogawa, M. and Mizuguchi, Y. (1985). Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47, 446-451.
12. Simpson, L. M. and Oliver J. D. (1983). Siderophore production by Vibrio vulnificus. Infect. Immun. 41, 644-649.
13. Wright, A. C., Powell, J. L., Tanner, M. K., Ensor, L. A., Karpas, A. B., Morris, J. G. Jr., and Sztein, M. B. (1999). Differential expression of Vibrio vulnificus capsular polysaccharide. Infect. Immun. 67 2250-2257.
14. Shinoda, S., Kobayashi, M., Yamada, H., Yoshida, S., Ogawa, M. and Mizuguchi, Y. (1987). Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol. Immunol. 31, 393-401.
15. Smith, A. B. and Siebeling, R. J. (2003). Identification of genetic loci required for capsular expression in Vibrio vulnificus. Infect. Immun. 71, 1091-1097.
16. Tanner,M. E. and Miao, S. (1994). The synthesis and stability of aziridino-glutamate, an irreversible inhibitor of glutamate racemase. Tetrahedron Lett. 35, 4073-4076.
17. Ashiuchi, M., Yoshimura, T., Esaki, N., Uneo, H. and Soda, K. (1993). Inactivation of glutamate racemase of Pediococcus pentosaceus with L-serine O-sulfate. Biosci. Biotechnol. Biochem. 57, 1978-1979.
18. de Almeida Leone, P., Carroll, A. R., Towerzey, L., King, G., McArdle, B. M., Kern, G., Fisher, S., Hooper, J. N. and Quinn, R. J. (2008). Exiguaquinol: A novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI. Org. Lett. 10, 2585-2588.
19. Hwang, K. Y., Cho, C.-S., Kim, S. S., Sung, H.-C., Yu, Y. G. and Cho, Y. (1999). Structure and mechanism of glutamate racemase from Aquifex pyrophilus. Nat. Struct. Biol. 6, 422-426.
20. Kim, K.-H., Bong, Y.-J., Park, J. K., Shin, K.-J., Hwang, K. Y. and Kim, E. E. (2007). Structural basis for glutamate racemase inhibition. J. Mol. Biol. 372, 434-443.
21. Lundqvist, T., Fisher, S. L., Kern, G., Folmer, R. H. A., Xue, Y., Newton, D. T., Keating, T. A., Alm, R. A. and de Jonge, B. L. M. (2007). Exploitation of structural and regulatory diversity in glutamate racemases. Nature 447, 817-822.
22. Ruzheinikov, S. N., Taal, M. A., Sedelnikova, S. E., Baker, P. J. and Rice, D.W. (2005). Substrate-induced conformational changes in Bacillus subtilis glutamate racemase and their implications for drug discovery. Structure 13, 1707-1713.
23. Dodd, D., Reese, J. G., Louer, C. R., Ballard, J. D., Spies, M. A. and Blanke, S. R. (2007). Functional comparison of the two Bacillus anthracis glutamate racemases. J. Bacteriol. 189, 5265-5275.
24. Gallo, K. A., Tanner, M. E. and Knowles, J. R. (1993). Mechanism of the reaction catalyzed by glutamate racemase. Biochemistry 32, 3991-3997.
25. Möbitz, H. and Bruice, T. C. (2004). Multiple substrate binding states and chiral recognition in cofactor-independent glutamate racemase: A molecular dynamics study. Biochemistry 43, 9685-9694.
26. Glavas, S. and Tanner, M. E. (1999). Catalytic acid/base residues of glutamate racemase. Biochemistry 38, 4106-4113.